1. Home
  2. CABA vs STRS Comparison

CABA vs STRS Comparison

Compare CABA & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.56

Market Cap

200.2M

Sector

Health Care

ML Signal

HOLD

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

N/A

Current Price

$22.82

Market Cap

168.1M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CABA
STRS
Founded
2017
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
200.2M
168.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CABA
STRS
Price
$2.56
$22.82
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
2.9M
7.5K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$31,912,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$15.10
52 Week High
$3.67
$26.98

Technical Indicators

Market Signals
Indicator
CABA
STRS
Relative Strength Index (RSI) 53.01 58.71
Support Level $2.32 $21.25
Resistance Level $2.69 $24.09
Average True Range (ATR) 0.21 0.80
MACD 0.03 0.26
Stochastic Oscillator 76.81 56.89

Price Performance

Historical Comparison
CABA
STRS

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

Share on Social Networks: